about
From functional genomics to functional immunomics: new challenges, old problems, big rewardsTeratogenic effects of the Zika virus and the role of the placentaA systematic bioinformatics approach for selection of epitope-based vaccine targetsComprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice modelReliable Classifier to Differentiate Primary and Secondary Acute Dengue Infection Based on IgG ELISAAlternative Complement Pathway Deregulation Is Correlated with Dengue SeverityIdentification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3)Gene Expression Profiling during Early Acute Febrile Stage of Dengue Infection Can Predict the Disease OutcomeDengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection.Dendritic cell-lysosomal-associated membrane protein (LAMP) and LAMP-1-HIV-1 gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopesHuman dendritic cell lysosome-associated membrane protein expressed in lung type II pneumocytesT-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifsRapid and specific detection of Asian- and African-lineage Zika viruses.Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype.Dendritic cell mediated delivery of plasmid DNA encoding LAMP/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic miceRegulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response.Risk of dengue for tourists and teams during the World Cup 2014 in Brazil.Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strengthIdentification of conserved and HLA promiscuous DENV3 T-cell epitopes.Molecular classification of outcomes from dengue virus -3 infections.Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil.A DNA vaccine against yellow fever virus: development and evaluation.Dengue virus specific dual HLA binding T cell epitopes induce CD8+ T cell responses in seropositive individuals.Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countriesSelection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomers.West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligandsAssociation between magnitude of the virus-specific plasmablast response and disease severity in dengue patientsSequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virusPlacental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.Comparison of DNA vaccines producing HIV-1 Gag and LAMP/Gag chimera in rhesus macaques reveals antigen-specific T-cell responses with distinct phenotypes.Complement factor H gene (CFH) polymorphisms C-257T, G257A and haplotypes are associated with protection against severe dengue phenotype, possible related with high CFH expression.Vaccine research, development, and innovation in Brazil: a translational science perspective.Mosquito-borne and sexual transmission of Zika virus: Recent developments and future directions.Central and peripheral nervous system involvement caused by Zika and chikungunya coinfection.Emerging concepts in dengue pathogenesis: interplay between plasmablasts, platelets, and complement in triggering vasculopathy.Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?Prospective birth cohort in a hyperendemic dengue area in Northeast Brazil: methods and preliminary results.Results of a Zika Virus (ZIKV) Immunoglobulin M-Specific Diagnostic Assay Are Highly Correlated With Detection of Neutralizing Anti-ZIKV Antibodies in Neonates With Congenital Disease.
P50
Q21145681-26810AFC-722E-48DB-8DE1-84BAD7101F5AQ23012830-25E71113-3B08-4BFE-8E1F-5E63CF42AADBQ27481378-27E0FEB0-908A-4B36-9D65-81B8FBD55491Q27487555-9E662D26-9426-4320-816F-0F686572AD6AQ27488250-65753DDA-DA89-4B98-BDC6-D66406BDF051Q27489374-51358172-E2BA-4692-8B4E-91DBA8D7B04DQ27489953-27E2371B-657A-4916-A6A2-0C2504146FC0Q27490377-98C2CF04-6BF0-439A-950E-14C6CADAF6D1Q28108975-3DADD4E6-D82A-43FD-A27C-A7AFC375C283Q28255785-01FA5431-4BC8-44D0-B4D8-E8CB4B31CA2EQ28258703-743FEA73-495D-4D7E-879E-5E23BFB859DFQ28485408-8CF872F0-31EA-4366-A7AD-3C01D66F3C2AQ30145652-52521412-053A-46B7-86CE-3A1E1BAEF32AQ30384675-4A3C4F2A-B0BE-44C6-B629-1EF45329346DQ33268303-76A3EC16-0BF9-4A47-86A9-940E00C9BC51Q33379050-A4E787AB-0BBE-48C1-9D84-5E0C6C1CE603Q33522216-CDCAA313-87A7-40A7-BA68-183BFB5DE463Q33763297-26CB28D9-DF0A-4FF8-95C6-E4E97FD28EBDQ33997466-2A87A4F2-D131-4A8B-99D4-AAEAF6956405Q34062468-7CB13FB2-B3DD-46A2-A33D-ECD4EB22A12DQ35018972-BACFDDBD-2467-4B7B-81D7-DCA3A0F1C478Q35138665-EABDEBE0-199B-49B2-B22B-4383D82D8B2BQ35246149-8236276A-881F-42E4-AF65-ED67265489B5Q35392195-EF1D94DE-14CB-4AD4-BF02-BCB1425EA288Q35886539-33F09D70-B42C-4AA4-AAA5-F8A57E89FC75Q35954329-5922BFDB-EEEF-4FF9-8DDB-1F49F27CDB15Q36018359-9035AAD6-ACA9-4B9F-B7E6-808228473AD2Q36155428-77A2DAE7-4EBC-4681-9BCB-452B1B272617Q36487320-8831F330-5967-48E5-884E-6FFF49AD1CB2Q36559914-5C5AF93A-26F4-4525-8990-C23C04B4D876Q37033074-A620307C-0783-4301-8A58-0CF686644841Q37344832-74FE5C75-C1E7-491A-B993-3375B08F2623Q37540534-530AEFEA-9F1E-4112-822B-3DC1C2B342B1Q38100049-5F5893D3-8413-44F0-BC3A-2422E0F28DD0Q38157853-29B12D13-3598-47C5-9CA7-CA26822A9658Q38157866-3118E89B-D544-46A6-B3DB-016A7FEC567AQ38221184-E04B3228-7138-48EF-996F-8905032EBDEBQ38542708-594F3CFF-7394-47E6-BEB4-7BB0F82D93CAQ38919411-49E196E8-D006-471E-A284-2E335E04159BQ38953219-C4A565EF-32FF-425F-A2CA-1CADAF7E623B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ernesto T A Marques
@ast
Ernesto T A Marques
@en
Ernesto T A Marques
@es
Ernesto T A Marques
@nl
type
label
Ernesto T A Marques
@ast
Ernesto T A Marques
@en
Ernesto T A Marques
@es
Ernesto T A Marques
@nl
prefLabel
Ernesto T A Marques
@ast
Ernesto T A Marques
@en
Ernesto T A Marques
@es
Ernesto T A Marques
@nl
P106
P2038
Ernesto_Marques
P21
P31
P496
0000-0003-3826-9358